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Huntington's disease is caused by specific mutations in huntingtin protein. Expansion of a polyglutamine (polyQ) repeat of huntingtin leads to
protein aggregation in neurons followed by cell death with apoptotic markers. The connection between the aggregation and the degeneration of
neurons is poorly understood. Here, we show that the physiological consequences of expanded polyQ domain expression in yeast are similar to
those in neurons. In particular, expression of expanded polyQ in yeast causes apoptotic changes in mitochondria, caspase activation, nuclear DNA
fragmentation and death. Similar to neurons, at the late stages of expression the expanded polyQ accumulates in the nuclei and seems to affect the
cell cycle of yeast. Interestingly, nuclear localization of the aggregates is dependent on functional caspase Yca1. We speculate that the aggregates
in the nuclei disturb the cell cycle and thus contribute to the development of the cell death process in both systems. Our data show that expression
of the polyQ construct in yeast can be used to model patho-physiological effects of polyQ expansion in neurons.
© 2006 Elsevier B.V. All rights reserved.Keywords: Huntingtin; Polyglutamine; Yeast; Mitochondria; Apoptosis1. Introduction
There are numerous studies showing that the budding yeast S.
cerevisiae is a useful model of the molecular mechanism of aging
(reviewed in [1,2]). Yeast appear to be a useful model to study
age-related degeneration of post-mitotic cells (see [3] for review).
The most popular model for this is a stationary culture of starving
yeast cells ([4,5]). It has been shown that, among other treatments
(reviewed in [6]), incubation of yeast in stationary cultures in-
duces apoptosis [4]. Moreover, yeast were successfully used to
model death of terminally differentiated neurons during various
types of pathologies (see [3] for review). In particular, the yeast
system provided certain insights into Parkinson disease [7,8] .
While it has been shown that mutant forms of synucleinmay form
inclusion bodies (IB) and cause apoptotic death of neurons in⁎ Corresponding author.
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doi:10.1016/j.bbabio.2006.05.004humans (reviewed in [9]), the mechanism of the disease deve-
lopment is largely unknown. To study the mechanism, the mutant
forms of the protein were expressed in yeast and inclusion body
(IB) formation followed by cell death were observed. Importantly,
similar to neuronal death, the death of yeast was accompanied by
the appearance of apoptotic markers [10].
Another example of a yeast-basedmodel of neuronal pathology
is expression of expanded poluglutamine (polyQ) fragment of
huntingtin (Htt1). The mutant form of Htt1 causes hereditary
neuronal degeneration in humans [11]. The degeneration is ac-
companied by polyQ-mediated aggregation of Htt1 and accu-
mulation of apoptotic markers in the affected neurons (see [12,13]
for reviews). When expressed in yeast, the polyQ-fragment also
forms IBs and appears to be toxic for cells [14,15]. While yeast
factors controlling aggregation of the polyQ fragment were ex-
tensively studied [14–17], it is not clear whether the polyQ-
triggered cell death pathways are similar for both yeast and
humans. Here, we show that, similar to neurons [18,19], in yeast
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mitochondrial fragmentation, caspase activation and cell death.
2. Materials and methods
Saccharomyces cerevisiae strains used in this study are derivatives of W303,
Mat a. The original strain was transformed with either 25Q-CFP- or 103Q-CFP-
expressing integrating constructs described in [14]. For polyQ expression, cellsFig. 1. Toxic effect of the expanded polyQ expression correlates with its accumulation
12 h were briefly fixed with ethanol and stained with Hoecst 33258 dye (1 μg/ml) to
both types of cells and both constructs are present in the cytosole. However, during
doubles its starting value and CFP can be seen in the nuclei (arrowheads). A small
staining of DNA (arrows). Scale bar — 10 μm.were pre-grown at 30 °C in YP-Raf (yeast extract with peptone [20], supple-
mented with 2% raffinose) and then transferred into YP-Raf/Gal (YP-Raf sup-
plemented with 2% galactose). Deletion of YCA1 was performed by replacing
the gene with the deletion construct amplified from the EUROSCARF yeast
strain collection. GAL-Cdc20 construct was described in [21].
Visualization of DNA, mitochondria and ROS were performed as described
in [22], Caspase visualization was performed as described in [23]. FACS
analysis and propidium iodide (PI) staining were performed as described in [24].
Alpha-tocopherol was used at 30 μM concentration.in the nuclei. Liquid cultures expressing either 25Q-CFP or 103Q-CFP for 6 and
reveal DNA. During the 0–6 h time period, the generation times are the same for
the 6–12 h time period, the average generation time of 103Q-expressing cells
but significant percentage of cells expressing 103Q for 12 h show fragmented
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tified using Colocalization Finder plug-in of ImageJ program. Percentage of
colocalization was calculated as the number of the colocalized pixels normalized
to Hoecst 33258 self-colocalization. At least 50 cells were analyzed for each
strain. Error bars correspond to S.E.M.3. Results and discussion
In the first series of experiments, we confirmed the data [15,16]
on the aggregation and toxicity of a fragment of Htt1 carrying the
N-terminal 17-amino-acid stretch followed by expanded polyQ
domain (103Q) in yeast. As shown by Fig. 1, the fragment con-
taining normal length polyQ-domain (25Q) accumulates diffusely
in the cells. In contrast, 103Q forms distinct aggregates (Fig. 1).
Interestingly, while after 6 h of induction these aggregates are found
mostly in the cytoplasm, photographs made after 12 h of 103Q
induction frequently show distinct nuclear localization of the frag-
ment (Fig. 1, arrow-heads). To estimate the toxicity of the fragment
expression, we measured the optical density (OD). The average
rates of growth between 0 and 6 h of induction were the same for
25Q- and 103Q-expressing cells, whereas during the time period of
6–12 h the increase in OD of 103Q-expressing cells was 2-fold
lower compared to that of 25Q-expressing cells (Fig. 1). Moreover,
cultures expressing 103Q for 12 h contain a fraction of abnormally
large dumbbell-shaped cells, suggesting a cell cycle delay. Thus the
expression of 103Q seems to affect the cell cycle, and its detri-
mental effect correlates in time with its nuclear localization. Impor-Fig. 2. The length of the polyQ-domain and alpha-tocopherol affect DNA content, ce
(A) show that after 12 h of 103Q (but not 25Q) expression, there is a significant fracti
the formation of this fraction of the cells (103Q+toco). (B) 103Q alleviates the toxicity
staining intensities are different in 25Q- (C) and 103Q-expressing cells (D). Dead ctantly, while normal huntingtin (Htt1) in neurons is localized to the
cytoplasm, the form carrying pathologically expanded polyQ do-
main accumulates in the nucleus (reviewed in [12]).
In the same set of experiments we noticed that a fraction of cells
expressing 103Q for 12 h was showing abnormal morphology of
nuclear DNA (Fig. 1, arrows). DNA in these cells appears to be
fragmented and scattered throughout the cytoplasm. It was shown
that, similar to higher model systems, DNA fragmentation (re-
viewed in [7]) and loss of nuclear envelope integrity [25] are mar-
kers of late apoptotic events in yeast. To estimate a percentage of
cells undergoing DNA cleavage as a consequence of polyQ ex-
pression, we performed cellular DNAmeasurement by FACS. Fig.
2A (top row) shows cells carrying 25Q construct at time points 0, 6
and 12 h after the induction. Two peaks correspond to the cells with
unreplicated (before S-phase) and replicated (after S-phase) DNA.
While cells expressing 103Q show similar FACS profiles at time
points 0 and 6 h, after 12 h following the induction the culture starts
to accumulate a significant proportion of cells with DNA content
less than 1C (Fig. 2A, arrow). Thus, 103Q expression leads toDNA
degradation, suggesting the induction of an apoptotic pathway.
We also noticed that the polyQ expression alters the ratios of
1C and 2C DNA peaks. With the most of the non-expressing
cells containing 1C DNA, the polyQ expression leads to the
increase of the 2C peak (Fig. 2A). This is consistent with the cell
cycle delay phenotype suggested by the presence of large
dumbbell cells in 103Q-expressing cultures (Fig. 1). What is the
nature of the 103Q-induced alteration of the cell cycle? It isll cycle and mitochondrial morphology in polyQ-expressing cells. FACS profiles
on of cells with less than 1C DNA content (arrow). Tocopherol addition prevents
of Cdc20 overexpression. Mitochondrial morphologies andMitotracker Orange
ells show strong non-specific Mitotracker staining (D). Scale bar — 10 μm.
Fig. 3. The polyQ-expressing cells grown on solid media for 24 h display apoptotic markers. (A) Similar to the liquid-grown cultures, 25Q accumulates diffusely in
the cytoplasm and mitochondria in these cells are filamentous and relatively weakly stained with Mitotracker; 103Q-expressing cells accumulate 103Q in the
nuclei (DNA staining not shown) and frequently contain bright and fragmented mitochondria. (B) While 25Q-expressing cells are ROS-negative, expression of
103Q drives ROS formation in a fraction of the cells. (C, D) Effects of alpha-tocopherol (30 μM) addition on the colony-forming properties of (C) and
mitochondrial morphology in (D) the 103Q-expressing cells. (E) Caspase activation in 103Q-expressing cells. Merged-color photographs show PolyQ constructs
in blue, PI— in red, FITC-VAD-fmk— in green. A minor fraction of the 25Q-expressing cells accumulate PI, but these cells are FITC-VAD-fmk negative (purple,
top panel). Expression of 103Q leads to formation of FITC-VAD-fmk — positive/PI-negative (dark green), FITC-VAD-fmk— positive/PI-positive (orange) and
FITC-VAD-fmk — negative/PI-positive cell types (bottom panel). Scale bars — 10 μm.
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promoting complex), thus delaying the exit from mitosis. To
address this possibility we tested the effect of polyQ expression
in cells with elevated APC level. The elevation of APC level
was achieved by expression of APC subunit Cdc20 using GAL1
promoter. These cells are unable to grow on YP-Raf/Gal due to
tight APC-induced arrest in G1 phase of the cell cycle [21].Interestingly, unlike the 25Q construct, 103Q expression did
allow a minor fraction of the cells to grow and form micro-
colonies (Fig. 2B). This result is consistent with the idea that the
103Q expression delays the cell cycle and suggests that the
delay is achieved via lowering the activity of APC.
It was previously shown that, similar to the mammalian cells,
yeast apoptosis is sometimes accompanied by the sharp transient
Fig. 4. Deletion of yca1 affects the intracellular localization of 103Q aggregates.
(A) In yca1-delta cells, unlike the control YCA1, nuclear DNA signal (red
channel) does not overlap with 103Q-CFP signal (green channel) Scale bar —
10 μm. (B) Quantification of the colocalization in the control 103Q-expressing
strain and in two independent yca1-delta 103Q-expressing transformants.
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within). To test whether 103Q expression causes such an increase,
we stained the cells that had expressed either 25Q or 103Q for 12 h
with the dye Mitotracker Orange. Mitotracker Orange was shown
to accumulate in mitochondria, dependent on the membrane po-
tential and was successfully used in yeast to estimate the extent of
mitochondrial hyperpolarization [22]. As shown by Fig. 2C and
D, mitochondria in 25Q-expressing cells are relatively weakly
stained, whereas 103Q-expressing cells tend to accumulate more
of the dye in their mitochondria. Themorphology ofmitochondria
also seems to be different for 25Q- and 103Q-expressing cells.
While 25Q-expressing cells contain filamentous mitochondria,
the brightly stained 103Q-expressing cells accumulate the dye in
separate round organelles. As mitochondrial fragmentation was
shown to be a hallmark of apoptosis in yeast and higher cells ([26],
also see [27] for review), the effect of 103Q on mitochondrial
morphology is another indication of the pro-apoptotic action of
103Q construct induction.
Increase of mitochondrial membrane potential can directly
cause accumulation of reactive oxygen species (ROS) in apoptotic
yeast cells [22]. It is known that ROS are an important intermediate
in the progression of an apoptotic cascade ([28], also see [27] for
review). To test whether quenching of ROS will affect the detri-
mental effects of 103Q expression, we added antioxidant alpha-
tocopherol to the cells expressing 103Q construct. While the addi-
tion had no or very small effect on the rate of the OD increase (data
not shown), quenching of ROS inhibited the DNA cleavage as
shown by FACS (Fig. 2A, 103Q+toco). Thus, while not relieving
the detrimental effect of 103Q on cell growth, alpha-tocopherol
seems to inhibit the final stages of cell death in the 103Q-expressing
cells. It suggests that in liquid yeast cultures, 103Q does not trigger
apoptosis directly but interferes with the normal functioning of the
cells upstream of the ROS production. In other words, apoptotic
death of 103Q-expressing yeast might be an indirect consequence
of its toxic activity. Nuclear localization of 103Q suggests that,
similar to mammalian systems, it may disturb the normal function
of yeast cells by acting as a transcription-influencing factor.
At the same time, in mammalian cell models of polyQ-medi-
ated diseases it was shown that the cell death is accompanied by
accumulation of apoptotic markers [29]. We wanted to see
whether, similar to mammalian cells, it is possible to detect an
apoptosis-dependent cell death effect of 103Q expression in yeast.
To do that, instead of liquid culture we grew yeast cells on solid
media. Consistent with [15,16], we found that after 24 h of
growth, the colonies formed by 103Q-expressing cells weremuch
smaller compared to the colonies of 25Q-expressing cells (data not
shown). Mitotracker Orange staining of yeast cells grown on solid
media showed that, similar to liquid culture, 103Q-expressing cells
contained hyperpolarized and fragmented mitochondria, while
mitochondria of the 25Q-expressing cells were filamentous and
relatively weakly stained (Fig. 3A).
Does the increase of the membrane potential drive ROS
formation in the cells grown on solid media? To test this we
added ROS-sensitive fluorescent dye H2-DCF-DA to the plate-
grown 25Q- and 103Q-expressing cells. While 25Q-expressing
cells were ROS-negative, a small (1–5%) and not entirely re-
producible amount of 103Q-expressing cells showed diffuseROS staining (Fig. 3B). Thus, our data suggest that high levels of
ROS in 103Q-expressing cells are transient and most likely
occur shortly before the cell death. The latter is suggested by
highly abnormal (swollen) appearance of the ROS-positive cells
(Fig. 3B).
Nevertheless, unlike liquid media, addition of alpha-tocoph-
erol had a noticeable effect on the growth of 103Q-expressing
yeast cells (Fig. 3C). To estimate the effect of alpha-tocopherolwe
plated equal amounts (approximately 1000) of yeast cells on YP-
Raf/Gal plates, incubated the plates for 24 h at 37 °C, collected the
microcolonies (Fig. 3C) by washing them off the plates in equal
volumes and thenmeasured the optical density of the suspensions.
The number of the cells estimated in this way was 2.6-fold higher
from the alpha-tocopherol-containing plate compared to the
control one. To confirm that in this experiment alpha-tocopherol
inhibited cell death, we estimated the fractions of the dead cells in
the suspensions. To do that we added Propidium Iodide (PI) to the
suspensions. The addition of alpha-tocopherol lowered the pro-
portion of the PI-positive cells from 15% to 7.5%.
By staining the plate-grown cells with Mitotracker Orange
we noticed that the morphology of mitochondria in plate-grown
cells seemed to be affected by alpha-tocopherol addition.
Fig. 3D shows that the addition of the antioxidant partly
prevented fragmentation of the mitochondrial network.
The major feature of apoptotic death, including apoptosis in
neurons, is activation of caspases [29]. Yeast caspase Yca1 has
been shown to play an essential role during apoptosis triggered by
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stationary culture [4]. To test whether caspase activity increases
during 103Q expression in yeast, we stained the cells grown on
solid media with FITC-VAD-fmk — a fluorescent caspase sub-
strate analog. We found that while cultures of 25Q-expressing
cells contained a small percentage of dead (PI-positive) cells, they
did not show any caspase-positive cells (Fig. 3E and data not
shown). On the contrary, 2-day old cultures of 103Q-expressing
cells contained large fractions of caspase-positive/PI-negative and
caspase-positive/PI-positive cells (Fig. 4E). Thus, 103Q expres-
sion leads to caspase activation in yeast.
What is the role of caspase in the polyQ-induced death? To test
that we introduced the 103Q construct in yeast caspase yca1
deletion mutant. We found that the absence of Yca1 did not rescue
significantly the detrimental effect of 103Q on the colony growth
(data not shown). Surprisingly, the deletion of yca1 strongly af-
fected the intracellular localization of the aggregates. Fig. 4A
shows that the absence of Yca1 prevented the accumulation of the
aggregates in the nuclei. Using ImageJ program (seeMaterials and
methods) we estimated the extent of the colocalization in the
control 103Q-expressing strain and in two independent yca1
deletionmutants. Fig. 4B shows that the overlap between 103Q and
DNA fluorescent signals was approximately 4 times lower in the
deletion mutants. Here it is important to mention that the polyQ-
expanded Htt1 accumulates in the nuclei in mammalian cells, and
this accumulation is thought to be linked to the proteolytic cleavage
of Htt1 (reviewed in [12]). In the case of 103Q expression in yeast,
we can rule out the cleavage of the fragment. First,Western blots of
103Q-expressing cells show a single band with a molecular weight
corresponding to the full-length construct (M. Sherman, unpub-
lished). Second, while CFP is fused to the C-terminus, the polyQ
stretch is at the very N-terminus of the yeast-expressed construct
[14]. Thus, unlike mammalian cells, translocation of 103Q to the
nuclei of yeast cells seems to be proteolysis-independent. At the
same time, in both systems nuclear localization of the aggregates
seems to be caspase-dependent. It is possible that the expanded
polyQ activates caspase, which in turn leads to the loss of the
nuclear permeability barrier.
What are the functional consequences of the nuclear trans-
location of the expanded polyQ-containing fragment? In mam-
malian cells polyQwas shown to bindCBP [30]— a transcription
factor. It was suggested that the IBs trigger neuronal degeneration
by sequestering CBP [30]. Recently, it was shown that CBP is a
direct binding partner of APC [31]. Thus, it is possible that the
toxic effect of the expanded polyQ in yeast and neurons are in part
due to the disruption of the cell cycle-regulating machinery. In-
deed, while neurons are post-mitotic cells, aging- and disease-
related degeneration of neurons is often accompanied by abortive
cell cycle initiation (see [32,33] for review). In particular, it was
shown that during Huntington's disease neurons start to accu-
mulate cyclin B— an indicator of cell cycle activation [32].
As for yeast, it was shown that deletion of the S-phase
checkpoint gene significantly increased apoptotic cell death in
the stationary culture [34,35]. Interestingly, 103Q-expressing
cells seem to have a delay in the S-phase: after 12 h of expression
the peaks of the cells containing 1C and 2C DNA are not as
clearly separated as in case of 25Q-expressing cells (Fig. 2A).To conclude, taken together with the previous observations,
our data allow to speculate that in both yeast and neurons the
expanded polyQ protein molecules aggregate in the nucleus,
causing cell cycle defects. These defects contribute to the pleio-
tropic toxic effects of the expanded polyQ expression and induce
cell death, accompanied by a set of apoptosis-linked changes in
mitochondria, caspase activation and DNA cleavage. We sug-
gest that a yeast-based system of the polyQ expression is an
appropriate model to study neuronal degeneration triggered by
aggregation of proteins with expanded polyQ domains.
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